This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Airbus vs. Boeing: (A), (B), (C), (D), (E), and (F), Teaching Note
Casadesus-Masanell, Ramon; Voigt, Erich Alexander; Mitchell, JordanTeaching Note HBS-710405-EStrategyTeaching Note for [707447], [707448], [707449]. [707450], [707451], and [707452].Starting at €0.00
-
Competir mediante modelos de negocio (C): Interdependencia, interacción táctica e interacción estratégica
Casadesus-Masanell, Ramon; Ricart Costa, Joan EnricCase HBS-711S24StrategyStarting at €5.74
-
Betfair (B), (C), and (D) Case Slides
Casadesus-Masanell, Ramon; Heilbron, JohnCase HBS-717520-EStrategyContains slides related to the Betfair B, C, and D cases.Starting at €5.74
-
Fake News at DER SPIEGEL (C): Organizational Changes
Dey, Aiyesha; Heese, Jonas; Labruyere, ToniaCase HBS-120005-EAccounting and ControlThis (C) case complements the case "Fake News at DER SPIEGEL (A)".Starting at €5.74
-
Accounting Outages at Plug Power? (C)
Heese, Jonas; Pacelli, Joseph; Barnett, JamesCase HBS-124019-EAccounting and ControlSet in June 2023, the C case explores Plug Power's recovery from its financial restatements, how it benefited from government subsidies, and new strategic alliances.Starting at €5.74
-
Betfair (C)
Casadesus-Masanell, Ramon; Heilbron, John; Campbell, NeilCase HBS-717518-EStrategyPrompted by a takeover bid from CVC, Betfair reassesses the strengths and weaknesses of the exchange model.Starting at €5.74
-
Imprimis (C)
Casadesus-Masanell, Ramon; Elterman, Karen; Appel, MarcCase HBS-717497-EEntrepreneurshipThis case is a supplement to Imprimis (Case A) and Imprimis (Case B). Set in 2015, it first describes Imprimis's decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the problem of high drug prices in the United States. Recent, drastic price hikes on pharmaceutical drugs, such as those initiated by Turing Pharmaceuticals under CEO ...Starting at €5.74
-
Launching Telmore (C)
Casadesus-Masanell, Ramon; Fernandez, Celso; Jobke, MoritzCase HBS-708416-EStrategySupplement to the (A) case. An abstract is not available for this product.Starting at €5.74
-
Palm (C): 2005
Casadesus-Masanell, Ramon; Boudreau, Kevin; Mitchell, JordanCase HBS-708516-EThis case series looks at three important inflection points in Palm's history that relate to decisions about its platform: when the company was debating whether to open its operating system (OS) for licensing to third-party hardware manufacturers; 2001, when the company was deciding whether to split into two separate companies; and, 2005, when the company was migrating from its own OS into Linux. (The last part, set in 2008, is an epilogue). By l...Starting at €5.74
-
Keroche (E): Considering Additional Capacity
Casadesus-Masanell, Ramon; Armerding, Pippa TubmanCase HBS-720394-EStrategyThis case describes Keroche's growth after entering the beer business in 2008. Although the company was operating at full capacity and not able to fulfill all of its orders, Tabitha Karanja had set a goal of growing Keroche's share of the Kenyan beer market from slightly over 1% to 20%. In 2010, Tabitha Karanja had invested US$2.5 million in a PET bottling line to increase capacity of Keroche's vodka drinks. However, in 2010, the government had p...Starting at €5.74